Literature DB >> 16046630

A novel system for continuous protein refolding and on-line capture by expanded bed adsorption.

Henrik Ferré1, Emmanuel Ruffet, Lise-Lotte B Nielsen, Mogens Holst Nissen, Timothy J Hobley, Owen R T Thomas, Søren Buus.   

Abstract

A novel two-step protein refolding strategy has been developed, where continuous renaturation-bydilution is followed by direct capture on an expanded bed adsorption (EBA) column. The performance of the overall process was tested on a N-terminally tagged version of human beta2-microglobulin (HAT-hbeta2m) both at analytical, small, and preparative scale. In a single scalable operation, extracted and denatured inclusion body proteins from Escherichia coli were continuously diluted into refolding buffer, using a short pipe reactor, allowing for a defined retention and refolding time, and then fed directly to an EBA column, where the protein was captured, washed, and finally eluted as soluble folded protein. Not only was the eluted protein in a correctly folded state, the purity of the HAThbeta2m was increased from 34% to 94%, and the product was concentrated sevenfold. The yield of the overall process was 45%, and the product loss was primarily a consequence of the refolding reaction rather than the EBA step. Full biological activity of HAT-hbeta2m was demonstrated after removal of the HAT-tag. In contrast to batch refolding, a continuous refolding strategy allows the conditions to be controlled and maintained throughout the process, irrespective of the batch size; i.e., it is readily scalable. Furthermore, the procedure is fast and tolerant toward aggregate formation, a common complication of in vitro protein refolding. In conclusion, this system represents a novel approach to small and preparative scale protein refolding, which should be applicable to many other proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046630      PMCID: PMC2279326          DOI: 10.1110/ps.051396105

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Refolding of protein inclusion bodies directly from E. coli homogenate using expanded bed adsorption chromatography.

Authors:  T H Cho; S J Ahn; E K Lee
Journal:  Bioseparation       Date:  2001

Review 2.  Preparative protein refolding.

Authors:  Anton P J Middelberg
Journal:  Trends Biotechnol       Date:  2002-10       Impact factor: 19.536

3.  Oxidative refolding chromatography: folding of the scorpion toxin Cn5.

Authors:  M M Altamirano; C García; L D Possani; A R Fersht
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

4.  Efficient inclusion body processing using chemical extraction and high gradient magnetic fishing.

Authors:  Anders Heebøll-Nielsen; Woo-Seok Choe; Anton P J Middelberg; Owen R T Thomas
Journal:  Biotechnol Prog       Date:  2003 May-Jun

5.  Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.

Authors:  M A Speed; D I Wang; J King
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  The rate-limiting steps for the folding of an antibody scFv fragment.

Authors:  M Jäger; A Plückthun
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

9.  Regeneration of bovine pancreatic ribonuclease A: detailed kinetic analysis of two independent folding pathways.

Authors:  D M Rothwarf; Y J Li; H A Scheraga
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

10.  Protein refolding at high concentrations using detergent/phospholipid mixtures.

Authors:  G Zardeneta; P M Horowitz
Journal:  Anal Biochem       Date:  1994-05-01       Impact factor: 3.365

View more
  3 in total

1.  Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein.

Authors:  Sune F L Justesen; Kasper Lamberth; Lise-Lotte B Nielsen; Claus Schafer-Nielsen; Søren Buus
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

2.  Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Authors:  Michael Rasmussen; Mikkel Harndahl; Anette Stryhn; Rachid Boucherma; Lise Lotte Nielsen; François A Lemonnier; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

3.  Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.

Authors:  Andreas M Hansen; Michael Rasmussen; Nicholas Svitek; Mikkel Harndahl; William T Golde; John Barlow; Vishvanath Nene; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2014-09-04       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.